Shanghai, China

Qinghua Mao

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: The Innovative Mind of Qinghua Mao

Introduction

Qinghua Mao is a prominent inventor based in Shanghai, China, known for his substantial contributions to the field of pharmaceuticals. With a portfolio of 9 patents, Mao has dedicated his career to developing novel compounds that have significant applications in drug development.

Latest Patents

Among his latest innovations, Qinghua Mao has developed a glucoside derivative that functions as an SGLT1 inhibitor. This compound is a breakthrough in the preparation of drugs targeting SGLT1 related diseases. Additionally, he has patented a class of coumarin-like cyclic compounds that serve as MEK inhibitors. These pharmaceutical compositions represent an important advancement in treating MEK-related conditions.

Career Highlights

Qinghua Mao has worked with several esteemed organizations, including Merck Sharp & Dohme Corporation and Cstone Pharmaceuticals. His experience in these companies highlights his expertise in pharmaceutical research and development, contributing to the advancement of medical science.

Collaborations

Throughout his career, Qinghua Mao has collaborated with notable colleagues such as Chun Sing Li and Andrew John Cooke. These partnerships have fostered a rich environment for innovation and have been integral to the success of his various projects.

Conclusion

Qinghua Mao's inventive spirit and dedication to addressing medical challenges through innovative compounds solidify his reputation as a leading figure in the pharmaceutical industry. His work not only exemplifies the innovative potential within the field but also inspires future inventors to pursue groundbreaking solutions for complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…